Tech Company Financing Transactions
Imagine Pharma Funding Round
Imagine Pharma, based in Pittsburgh, secured $32.5 million in investment from IP Investors and private investors.
Transaction Overview
Company Name
Announced On
10/31/2023
Transaction Type
Venture Equity
Amount
$32,500,000
Round
Series A
Investors
IP Investors (Lead Investor)
private investors (John Callaghan)
Proceeds Purpose
The company intends to use the funds to advance its priority programs in regenerative medicine, oral delivery, and therapeutics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1401 Forbes Ave 312
Pittsburgh, PA 15219
USA
Pittsburgh, PA 15219
USA
Phone
Undisclosed
Website
Email Address
Overview
Imagine Pharma is a biotechnology company focused on the development of its IMG-1 polypeptide. Research and development efforts have led to the development of three distinctive platforms each with first-in-class programs that address multiple disease states in large underserved markets. Imagine Pharma has assembled a world-class team of scientists, clinicians and executive leaders with extensive experience in research, drug discovery and development and innovative clinical therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ngoc Thai
Co-Founder
Santiago Pujadas
Browse more venture capital transactions:
Prev: 10/31/2023: QI Tech venture capital transaction
Next: 11/1/2023: Snowflake venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs